Atlas Trials

Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT03190525 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03190525
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2017-11-13
Primary completion
2025-12-01
Enrollment
530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.